Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio studyMichela Giustozzi, Jean M Connors, Ana Belen Ruperez Blanco, et al.
Hemasphere|August 4, 2022
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With CancerAnna Falanga, Avi Leader, Chiara Ambaglio, et al.
Anticancer Research|February 11, 2015
Left ventricular systolic dysfunction in metastatic breast cancer patients: a Polish multicenter registrySebastian Szmit, Joanna Streb, Wioletta Starzec, et al.
Kardiologia Polska|June 26, 2014
[Role of echocardiography in monitoring of cardiac toxicity of cancer pharmacotherapy. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging]Grzegorz Piotrowski, Rafał Gawor, Zenon Gawor, et al.
Cancers|February 25, 2023
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after ChemoradiotherapyMagdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, et al.
Current Oncology Reports|April 15, 2021
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program BuildingDiego Sadler, Anita Arnold, Joerg Herrmann, et al.
Thrombosis and Haemostasis|May 5, 2020
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-AnalysisMichela Giustozzi, Giancarlo Agnelli, Jorge Del Toro-Cervera, et al.
Cancers|April 27, 2024
Safety and Outcomes of Inferior Vena Cava Filter Placement in Oncology Patients: A Single-Centre ExperiencePaweł Kurzyna, Marta Banaszkiewicz, Michał Florczyk, et al.
Thrombosis and Haemostasis|May 13, 2026
Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World AnalysisOlga Demska, Jean-Christophe Ianotto, Marta Szandruk-Bender, et al.
International Journal of Cardiology|March 8, 2017
Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disordersSebastian Szmit, Wojciech Jurczak, Jan Maciej Zaucha, et al.
Pageof 9